CCS
ELV icon

Crosspoint Capital Strategies’s Elevance Health ELV Stock Holding History

Crosspoint Capital Strategies’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-29
Closed -$4K – 1058
2015
Q3 		$4K Buy
+29
New +$4.36K ﹤0.01% 531

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Crosspoint Capital Strategies's ELV Position: Q4 2015 in Review

Crosspoint Capital Strategies sold out of Elevance Health (ELV) in Q4 2015, closing a stake of 29 shares — an estimated $4K sold.

Crosspoint Capital Strategies first reported a position in ELV in Q3 2015 and held it in 1 quarter. The position peaked at $4K in Q3 2015. 764 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

  • Crosspoint Capital Strategies reported no remaining Elevance Health position as of Q4 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 29 Elevance Health shares in Q4 2015, an estimated $4K.
  • Crosspoint Capital Strategies first reported a position in Elevance Health in Q3 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Elevance Health position peaked at $4K in Q3 2015.
  • 764 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2015, filed 16 Feb 2016.